new_0222_0617|INZY|Short Name|0|0|total_current_assets|cash_on_hand|inventories_net|net_ppe|goodwill_and_intangible|liabilities|total_current_liabilities|total_long_term_liab|total_deposits|book_value_of_equity|retained_earnings|treasury_stock|ev_revenues|ev_earnings|ev_free_cash_flow|ev_assets|ps_ratio|pe_ratio|price_to_book_value|peg_ratio|debt_equity_ratio|dividend_yield|shareholder_yield_ttm|percent_of_shares_outstanding|receivables|payables|capital_stock|return_on_invested_capital|quality_ratio_fractile|momentum_fractile|market_beta_12_month|sustainable_growth_rate|institutional_investor_ownership_percentage|average_shares_outs_diluted|total_employee_number|eps|shares_outstanding|repurchase_of_capital_stock|ordinary_shares_number|payout_ratio|quick_ratio|normalized_eps|stock_buyback|effective_tax_rate|return_on_equity|net_income_ttm|revenues_ttm|dividend_per_share|revenues|gross_profit|sga_expense|pre_tax_income|net_income|interest_income|price|total_return_price|enterprise_value|average_volume_30|one_year_return
new_0222_0617|INZY|Long Name|1|1|Inozyme Pharma Inc Total Current Assets (Quarterly) (USD)|Inozyme Pharma Inc Cash and Short Term Investments (Quarterly) (USD)|Inozyme Pharma Inc Inventories (Quarterly) (USD)|Inozyme Pharma Inc Net PP&E (Quarterly) (USD)|Inozyme Pharma Inc Goodwill and Intangibles (Quarterly) (USD)|Inozyme Pharma Inc Total Liabilities (Quarterly) (USD)|Inozyme Pharma Inc Total Current Liabilities (Quarterly) (USD)|Inozyme Pharma Inc Total Long Term Liabilities (Quarterly) (USD)|Inozyme Pharma Inc Total Deposits (Quarterly) (USD)|Inozyme Pharma Inc Book Value (Quarterly) (USD)|Inozyme Pharma Inc Retained Earnings (Quarterly) (USD)|Inozyme Pharma Inc Treasury Stock (Quarterly) (USD)|Inozyme Pharma Inc EV to Revenues|Inozyme Pharma Inc EV to Earnings|Inozyme Pharma Inc EV to Free Cash Flow|Inozyme Pharma Inc EV to Assets (Quarterly)|Inozyme Pharma Inc PS Ratio|Inozyme Pharma Inc PE Ratio|Inozyme Pharma Inc Price to Book Value|Inozyme Pharma Inc PEG Ratio|Inozyme Pharma Inc Debt to Equity Ratio|Inozyme Pharma Inc Dividend Yield|Inozyme Pharma Inc Shareholder Yield (TTM)|Inozyme Pharma Inc Percent of Shares Outstanding Short|Inozyme Pharma Inc Total Receivables (Quarterly) (USD)|Inozyme Pharma Inc Total Payables (Quarterly) (USD)|Inozyme Pharma Inc Total Capital Stock (Quarterly) (USD)|Inozyme Pharma Inc Return on Invested Capital|Inozyme Pharma Inc Quality Ratio Score|Inozyme Pharma Inc Momentum Score|Inozyme Pharma Inc Beta (1Y)|Inozyme Pharma Inc Sustainable Growth Rate (TTM)|Inozyme Pharma Inc Institutional Investor Ownership Percentage|Inozyme Pharma Inc Average Diluted Shares Outstanding (Quarterly)|Inozyme Pharma Inc Total Employees (Annual)|Inozyme Pharma Inc EPS Diluted (Quarterly) (USD)|Inozyme Pharma Inc Shares Outstanding|Inozyme Pharma Inc Repurchase of Capital Stock (Quarterly) (USD)|Inozyme Pharma Inc Ordinary Shares Number (Quarterly)|Inozyme Pharma Inc Payout Ratio|Inozyme Pharma Inc Quick Ratio (Quarterly)|Inozyme Pharma Inc Normalized Diluted EPS (Quarterly) (USD)|Inozyme Pharma Inc Stock Buybacks (Quarterly) (USD)|Inozyme Pharma Inc Effective Tax Rate (TTM)|Inozyme Pharma Inc Return on Equity|Inozyme Pharma Inc Net Income (TTM) (USD)|Inozyme Pharma Inc Revenue (TTM) (USD)|Inozyme Pharma Inc Dividend Per Share (Quarterly) (USD)|Inozyme Pharma Inc Revenue (Quarterly) (USD)|Inozyme Pharma Inc Gross Profit (Quarterly) (USD)|Inozyme Pharma Inc SG&A Expense (Quarterly) (USD)|Inozyme Pharma Inc Pre-Tax Income (Quarterly) (USD)|Inozyme Pharma Inc Net Income (Quarterly) (USD)|Inozyme Pharma Inc Net Interest Income (Quarterly) (USD)|Inozyme Pharma Inc Price (USD)|Inozyme Pharma Inc Total Return Price (USD)|Inozyme Pharma Inc Enterprise Value (USD)|Inozyme Pharma Inc 30-Day Average Daily Volume|Inozyme Pharma Inc 1 Year Price Returns (Daily)
new_0222_0617|INZY|Unit|2|2|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|percent_USD_metric|percent_USD_metric|percent_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|percent_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_beta|percent_USD_metric|percent_USD_metric|mil_figure_USD_metric|figure_whole_USD_metric|figure_money_USD_per_share_metric|mil_figure_USD_metric|mil_figure_money_USD_metric|mil_figure_USD_metric|percent_USD_metric|figure_USD_metric|figure_money_USD_per_share_metric|mil_figure_money_USD_metric|percent_USD_metric|percent_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|figure_money_USD_per_share_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|figure_money_USD_price|figure_money_USD_price|mil_figure_money_USD_metric|figure_USD_metric|percent_USD_metric
new_0222_0617|INZY||4|4|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|daily|quarterly|quarterly|quarterly|daily|quarterly|quarterly|daily|quarterly|monthly|quarterly|quarterly|quarterly|quarterly|quarterly|monthly|monthly|quarterly|quarterly|quarterly|quarterly|quarterly|monthly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|daily|daily|daily|daily|daily
new_0222_0617|INZY||5|5|91.2857142857|91.2857142857|0|91.2857142857|0|91.2857142857|91.2857142857|91.2857142857|0|91.2857142857|91.2857142857|0|0|0|1.44696969697|0|0|0|1.44571428571|0|0|1.44696969697|0|15.25|91.2857142857|91.2857142857|91.2857142857|0|0|30.6|30.6666666667|0|0|91.4|167|91.4|34|0|91.2857142857|0|0|91.4|91.375|0|0|91.2857142857|0|0|0|0|91.4|91.4|91.4|91.4|1.44584382872|1.44584382872|1.44696969697|1.44959128065|1.43055555556
new_0222_0617|INZY||6|6|7|7|0|7|0|7|7|7|0|7|7|0|0|0|396|0|0|0|350|0|0|396|0|36|7|7|7|0|0|5|6|0|0|10|1|10|14|0|7|0|0|10|8|0|0|7|0|0|0|0|10|10|10|10|397|397|396|367|144
new_0222_0617|INZY||7|7|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|daily|quarterly|daily|quarterly|daily|daily|daily|daily|quarterly|daily|quarterly|daily|quarterly|quarterly|quarterly|quarterly|quarterly|monthly|monthly|quarterly|monthly|quarterly|yearly|quarterly|daily|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|market_daily|market_daily|daily|market_daily|market_daily
new_0222_0617|INZY|201903|201903|201903||||||||||||||||||||||||||||||||||15.1592||-0.3279||||||-0.3279|||||||||1.03|-4.971|-4.971|0.21|||||
new_0222_0617|INZY|201906|201906|201906||||||||||||||||||||||||||||||||||15.1592||-0.2753||||||-0.2753|||||||||1.064|-4.173|-4.173|0.394|||||
new_0222_0617|INZY|201909|201909|201909||||||||||||||||||||||||||||||||||15.1592||-0.2662||||||-0.2662|0||||||||1.003|-4.035|-4.035|0.288|||||
new_0222_0617|INZY|201912|201912|201912|47.46|47.132||0.298||81.163|3.236|77.927||-33.219|-34.652||||||||||||||0.104|0.901|0|||||||15.1592||-0.4317|||20.3149|||-0.4317|0|||-19.723|||||1.489|-6.544|-6.544|0.214|||||
new_0222_0617|INZY|202003|202003|202003|74.963|74.54||0.374||4.909|4.909|0||70.827|-60.149||||||||||||||0.044|1.569|0.001|||||||15.1592||-0.5104|||20.3149|||-0.5104||||-22.49|||||1.5|-7.738|-7.738|0.171|||||
new_0222_0617|INZY|202006|202006|202006|64.66|63.867||0.846||118.53|6.727|111.803||-50.019|-51.863||||||||||||||0.082|1.399|0|||||||20.3149||-0.4663|||20.3149|||-0.4663||||-27.79|||||1.671|-9.473|-9.473|0.071|||||
new_0222_0617|INZY|202007|202006|202006|||||||||||||||-16.5098|||||||0||0.2962|||||||||||24||23.3649||||||||||||||||||19.55|19.55|392.9168||
new_0222_0617|INZY|202008|202006|202006|||||||||||||||-26.7496|||||||0||0.1953|||||||||||||23.3649||||||||||||||||||29.98|29.98|636.6127||
new_0222_0617|INZY|202009|202009|202009|163.977|159.502||2.455||11.077|9.814|1.263||167.916|-79.958||||-14.5808||||3.6582|||0||1.5378|0.252|3.665|0.002|||||||18.1015||-1.55|23.3649||23.3649|||-1.55|-116.988|||-51.85|||||3.142|-28.095|-28.095|0.064|26.29|26.29|454.7612|103835.5333|
new_0222_0617|INZY|202010|202009|202009|||||||||||||||-12.0937||||3.1962|||0||2.2141|||||||||||||||||||||||||||||||22.97|22.97|377.1898|59286.8333|
new_0222_0617|INZY|202011|202009|202009|||||||||||||||-14.3851||||3.6218|||0||3.0874|||||||||||||23.3728||||||||||||||||||26.02|26.02|448.6583|42693.7|
new_0222_0617|INZY|202012|202012|202012|150.979|147.697||2.648||11.26|9.973|1.287||158.103|-91.076||||-9.1667||||3.0529|||0||2.3136|0.155|3.069|0.002|||||||23.385|38|-0.4754|23.385||23.385|||-0.4754|1.016|||-56.424|||||4.235|-11.118|-11.118|0.064|20.64|20.64|334.9694|42847.2|
new_0222_0617|INZY|202101|202012|202012|||||||||||||||-9.4227||||3.112|||0||2.3346|||||||||||||||||||||||||||||||21.04|21.04|344.3234|44718.4|
new_0222_0617|INZY|202102|202012|202012|||||||||||||||-8.7571||||2.9582|||0||4.7233|||||||||||||||||||||||||||||||20|20|320.003|75726|
new_0222_0617|INZY|202103|202103|202103|148.041|145.086||5.029||10.026|6.832|3.194||148.889|-102.126||||-7.4975||||3.1216|||0||5.6439|0.122|1.709|0.002|||||||23.4295||-0.47|23.4737||23.4737|||-0.47||||-59.736|||||4.369|-11.05|-11.05|0.063|19.8|19.8|319.6933|58901.4|
new_0222_0617|INZY|202104|202103|202103|||||||||||||||-6.7708||||2.9135|||0||6.1513|||||||||||||23.4737||||||||||||||||||18.48|18.48|288.708|50298.6667|
new_0222_0617|INZY|202105|202103|202103|||||||||||||||-5.6074||||2.5803|||0||3.7994|||||||||||||23.4831||||||||||||||||||16.36|16.36|239.0975|35555.4|
new_0222_0617|INZY|202106|202106|202106|140.962|137.464||4.859||9.985|6.972|3.013||138.274|-114.666||||-5.9819||||2.9047|||0||5.5215|0.095|0.796|0.002|||||||23.4906||-0.53|23.5706||23.5706|||-0.53||||-62.803|||||4.435|-12.54|-12.54|0.058|17.04|17.04|264.179|77266.2667|
new_0222_0617|INZY|202107|202106|202106|||||||||||||||-5.8378||||2.8587|||0||1.5755|||||||2.4875||||||||||||||||||||||||16.77|16.77|257.815|87516.4|-15.6439
new_0222_0617|INZY|202108|202106|202106|||||||||||||||-5.1491||||2.6387|||0||1.5279||||||2|1.2308||||||23.6616||||||||||||||||||15.42|15.42|227.3979|46195.5|-48.5657
new_0222_0617|INZY|202109|202109|202109|130.579|125.283||4.743||11.772|8.943|2.829||125.974|-128.946||||-3.2562||||2.1772|||0||0.9628|0.073|0.626|0.002|||2|1.6771|||23.6435||-0.6|23.6647||23.6647|||-0.6|0|||-48.988|||||4.916|-14.28|-14.28|0.047|11.59|11.59|148.9909|120419.3|-55.9148
new_0222_0617|INZY|202110|202109|202109|||||||||||||||-2.0925||||1.7546|||0||0.799||||||1|1.2387||||||||||||||||||||||||9.34|9.34|95.7453|92003.9667|-61.3251
new_0222_0617|INZY|202111|202109|202109|||||||||||||||-1.3684||||1.4916|||0||0.7725||||||1|0.5136||||||23.6647||||||||||||||||||7.94|7.94|62.6147|27301.3|-69.485
new_0222_0617|INZY|202112|202112|202112|||||||||||||||-0.7892||||1.2812|||0||0.6465||||||1|0.5708||||||||||||||||||||||||6.82|6.82|36.1103|66718.9667|-66.9574
new_0222_0617|INZY|202201|202112|202112|||||||||||||||-0.7168||||1.2549|||0||1.1036||||||2|0.3154||||||||||||||||||||||||6.68|6.68|32.7972|68546|-68.251
new_0222_0617|INZY|202202|202112|202112|||||||||||||||-0.8306||||1.2492|||0|||||||||||||||||||||||||||||||||6.65|6.65|38.0034|58815.3333|-65.6375